Article
IL-13R130Q modulates human airway smooth muscle cell phenotype to contribute to severe asthma
2022-06-15
Abstract excerpt
<h4>Background: </h4> A small percentage of asthma patients experience severe and refractory asthma that responds poorly to standard therapy. However, this percentage is increasing and better treatment options are therefore needed. Our previous study showed that cultured human airway smooth muscle cells treated with IL-13 R130Q, a naturally occurring IL-13 variant, displayed enhanced functional activities compared...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 87e529da-3c89-5eef-ad6d-7a9a1e04b9d1
- DOI
- 10.21203/rs.3.rs-1741583/v1
